Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 38,739 $ 64,322
Accounts receivable 12,135 5,006
Inventories, net 11,483 8,090
Deferred fulfillment costs 9,917 3,971
Prepaid expenses 3,421 4,293
Contract assets 7,854 7,333
Other current assets 988 1,254
Total current assets 84,537 94,269
Property and equipment - net 9,885 10,810
Operating lease right of use assets 7,257 7,485
Restricted cash 1,254 1,254
Other non-current assets 23 23
Total assets 102,956 113,841
Current liabilities:    
Accounts payable 7,614 5,290
Accrued expenses 11,056 10,698
Contract liabilities 27,868 15,923
Other current liabilities 1,060 1,039
Total current liabilities 47,598 32,950
Share-based compensation liability 2,139 1,089
Warrant Liabilities 4,875 885
Operating lease liabilities, noncurrent 8,314 8,590
Total liabilities 62,926 43,514
Stockholders' equity    
Common stock - Class A shares, $0.0001 par value; 385,000,000 shares authorized, 236,695,241 and 234,844,952 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively; Class C shares, par value $0.0001, 5,750,000 shares issued and outstanding as of March 31, 2023 and December 31, 2022 25 25
Additional paid-in capital 484,411 478,219
Accumulated deficit (444,367) (407,878)
Accumulated other comprehensive (loss) (39) (39)
Total stockholders' equity 40,030 70,327
Total liabilities and stockholders equity $ 102,956 $ 113,841